‘Tis the season to be jolly—and to recap the top stories of the year from Xconomy Boston.
As always, these aren’t necessarily the highest-traffic stories, though in some cases they are. More importantly, they are stories that best represent what we as a staff try to deliver to our readers every day: real stories, features, narratives, Q&As, and news analysis about the people, companies, and trends that are shaping the future of innovation in New England and beyond.
With just a little more ado…let me tell you that our picks for 2012 span the fields of software, mobile, e-commerce, health and fitness, travel, politics, fashion, angel investing, venture capital, talent clusters, big data, drugs, genomics, life sciences, health IT, water, energy, and even a fast underwater ship.
It’s an even more diverse selection than usual, by my count. One common thread: the fascinating people, ideas, and strategies behind the headlines.
Just like the Oscars, a slight preference was shown to stories from late in the year. But only slight. (Look, otherwise you’d have to sit through a “Top Stories of Q4” post in addition to this one.) And no, I’m not going to say anything specific about Boston-area trends in this post; but you can scan the headlines and get a sense for some of the important things that happened this year.
OK, here are the stories, sorted by sector:
Top 10 Tech Stories of 2012
Amazon’s Boston Expansion: Cloud, Kiva, Digital Product Jobs
Gemvara CEO Matt Lauzon Steps Down: Thoughts on Startup Legacy and Future
RunKeeper’s Marathon Plan for Startup Success: “We’re Not in a Rush”
Top Angel Investors of New England: An Innovation Slideshow
Dan Weinreb, Boston Computer Geek, Community Figure, Dies of Cancer
Boom or Bust? 11 Big Bets on the Future of Boston Tech
Juliet Marine’s “Ghost” Ship Emerges from Stealth Startup, Gears Up for War
Massachusetts’ New Big-Data Initiative to Include MIT, Intel, and HackReduce
From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
Google, ITA, and the Future of Travel: It’s All About Data, Not Search
Top 10 Life Sciences and Cleantech Stories of 2012
Xconomist of the Week: Alexis Borisy Still Likes Early Stage Biotechs
A123 Goes on the Auction Block: Here’s How It Got This Bad
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug”
Massachusetts Water Mission to Israel Looks to “Win Inbound Innovation”
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster
After Big Oops, Vertex Plows Ahead with Cystic Fibrosis Drug Combo
Gamification Hits Healthcare as Startups Vie for Cash and Partners
Ready or Not, Genomics Is Coming to a Hospital Near You
Xconomist of the Week: Tom Maniatis on Prize4Life and ALS Research
Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks
